ncRNA2026: From Molecular Mechanisms to Clinical Impact
MDPI is excited to host ncRNA2026: From Molecular Mechanisms to Clinical Impact, the 3rd event in the ncRNA conference series, From Mechanism to Therapy. Taking place in Leuven, Belgium, the in-person event will run from 24 to 26 June 2026, bringing together experts in the field of non-coding RNA.
With important deadlines approaching, this article provides all the details you need to know about this conference.
What is the purpose of ncRNA2026?
In recent years, ncRNA studies have revolutionised our understanding of gene regulation, cellular networks, and disease mechanisms. The ncRNA2026 conference will bring together the ncRNA community to exchange ideas, present discoveries, and foster collaborations in the field. The event will showcase the latest breakthroughs in ncRNA biology and technology, from molecular mechanisms and clinical applications to data science and translational insights.
Alongside experts in the field, the event will welcome patient advocates and industry representatives and feature distinguished international invited speakers.
Schedule overview
The conference will host sessions on:
- Technological advances in ncRNA research
- Clinical applications and therapeutic innovation in ncRNA
- Emerging ncRNA classes and functional mechanisms
- AI and ncRNA research
- ncRNA roles and development in plants and bacteria
The above sessions will be delivered by the following invited speakers:
- Janusz Bujnicki – Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology, Poland
- Carlo Croce – Molecular, Cellular and Developmental Biology Program, The Ohio State University, USA
- Elisabetta Ferretti – Oncogenomic Research Unit, Department of Experimental Medicine, Sapienza University, Italy
- Maite Huarte – DNA & RNA Medicine Division, CIMA, University of Navarra, Spain
- Francesco Nicassio – Center for Genomic Science, Italian Institute of Technology (IIT), Italy
- Norbert Polacek – Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Switzerland
- Panagiotis Roussos – Icahn School of Medicine at Mount Sinai, USA
- Frank J. Slack – HMFP Pathology, Harvard, USA
- Mario Leonardo Squadrito – Vector engineering and in vivo tumor targeting group, San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Italy
- Igor Ulitsky – Weizman Institute of Science, Israel
Event awards
In celebration of the 10th anniversary of the Non-Coding RNA journal, MDPI is pleased to announce 20 Travel Awards for oral presentations at the conference.
MDPI’s awards programme ensures that the outstanding contributions of academics are recognised. To learn more about the Non-Coding RNA journal awards, click here.
Participating in ncRNA2026
Attendees can submit abstracts for a chance to present their work in the form of oral and/or poster presentations until 24 April 2026. Authors will be notified of acceptance by 4 May 2026.
Registration for ncRNA2026 will be open until 17 June 2026 – please note that the number of participants is limited.
For attendees who have submitted an abstract to present at the conference, the covering author must register by 10 May 2026. Abstracts without completed registration by this date will be withdrawn.
Attendees also have the exciting opportunity to contribute a full manuscript to the Special Issue Non-Coding RNA: 10th Anniversary.
To find out more details about the upcoming conference and how to get involved, you can visit the homepage on Sciforum. Keep an eye on our conferences blog page to stay up to date with upcoming MDPI conferences.
